<DOC>
	<DOC>NCT00267176</DOC>
	<brief_summary>This study will investigate the effect on ambulatory blood pressure of lumiracoxib 100 mg once daily versus ibuprofen 600 mg three times a day in osteoarthritis patients with controlled hypertension.</brief_summary>
	<brief_title>Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Osteoarthritis of the hand, hip, knee or spine High blood pressure (&lt;140/ 90 mmHg) which is controlled by antihypertensive medication(s). Exclusion criteria â€¢ Evidence or history of any cardiac and cerebral thrombotic/ ischemic diseases and/ or events Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Osteoarthritis,</keyword>
	<keyword>hypertension,</keyword>
	<keyword>lumiracoxib,</keyword>
	<keyword>ibuprofen,</keyword>
	<keyword>24-hour blood pressure profile</keyword>
</DOC>